Ethics Review, Guidelines & Regulations, IRB

Beyond Quick Turnaround Times: IRB Delegated/Expedited Review Explained

Delegated IRB review is an exception to the general requirement of a review by a full panel of the IRB. Some research applications may be delegated to a single member of the IRB or a subgroup of the IRB when specific expertise is required.  The IRB delegated review process is also referred to as the expedited review process. […]

Central IRB, Clinical Trials, Data Collection, Guidelines & Regulations, Uncategorised

Veritas IRB Approved in Saskatchewan as a Research Ethics Committee

Montreal, QC – August 8, 2017 – Veritas IRB is proud to announce that it has been approved by the Ministry of Health in Saskatchewan to perform research ethics review in the province. According to the Ministry of Health’s order No. 2017-06 of May 2, 2017, Veritas IRB has specifically been approved as a Research […]

Case Study, Clinical Trials, Crisis Management, Guidelines & Regulations, Informed Consent, Research Participants

A Tribute to Ellen Roche

In recognition of World Asthma Day, we wish to underline the importance of pursuing clinical research in order to improve the quality of life for the 300 million people affected by this disease. It is also important to remember those, like Ellen Roche, who participated in such clinical research. Ellen Roche was an employee at […]

Clinical Trials, Guidelines & Regulations, Informed Consent

The Revised Common Rule:
Trans-border Research and Henrietta Lacks

It is refreshing to see policy changes influenced by the evolution of science as opposed to crisis. The increased engagement of research participants in research coupled with increasing complexities in the research landscape have catalyzed revisions to the Common Rule. Inspired by the Belmont Report, the Common Rule was developed to ensure that research involving […]

en, Guidelines & Regulations

Am I IRB Forum Shopping? – Introduction

We recently revisited the Montreal tuberculosis outbreak wherein we identified IRB Forum Shopping as the root cause of this tragedy. IRB Forum Shopping is an under-researched yet highly-relevant ethical issue in the context of the North American governance of clinical research. Essentially, it is the practice of choosing an IRB based on the relative ease […]

en, Guidelines & Regulations

Will Health Canada still acknowledge clinical trial notifications?

On July 30, 2014, Health Canada announced that the Office of Clinical Trials of the Therapeutic Products Directorate (TPD) will cease issuance of ‘Acknowledgement of Notification’ letters for Clinical Trial Application Notifications (CTA-Ns) on September 1, 2014. What does this mean for your clinical trial? First off, this change applies only to clinical trials involving […]